What DP Technology does

DP Technology (Beijing Deep Potential Technology Co., Ltd., 深势科技) is a private AI for Science company founded in 2018 and headquartered in Haidian, Beijing. The company builds AI-native scientific discovery infrastructure, anchored by its proprietary Deep Potential molecular dynamics models and the 深势·宇知 (DP Scientific Discovery Intelligence Engine). It serves scientists and R&D organizations in life sciences (drug design, hit discovery, molecular computation), materials science (new energy, batteries, advanced materials), and academic research (chemistry, physics, biology) across China and North America.

Its product architecture follows a platform-plus-modules model. The Bohrium (玻尔) ecosystem functions as the connective layer, providing scientific navigation, a journal library, and access to 20M+ active global scholars, while Lebesgue (勒贝格智算) handles intelligent computing and Uni-Lab (跃迁实验室) integrates software with laboratory hardware. On top of this platform, the company sells specialized applications: Hermite for drug computation, RiDYMO for high-quality hit discovery, Piloteye for materials science R&D, and SciMaster as a scientific AI agent. Compute orchestration is delivered through Nodes, Workspace, and Jobs, supporting elastic heterogeneous computing at the "大装置" (large-scale scientific facility) layer.

The business model combines recurring SaaS subscriptions (Bohrium platform access), enterprise AI solutions (customized for pharma and materials organizations), and project-based R&D services. The company is sales-led with dedicated business development, investor relations, and HR channels, supported by a hybrid distribution approach that pairs direct enterprise sales with self-serve platform access. Operating geographies span Beijing, Shanghai, Shenzhen, and Yibin in China, with a US subsidiary (Atombeat Inc., Jersey City, NJ) handling North American enterprise coverage. As of late 2025, the company has 101–250 employees and has raised over US$250 million cumulatively, including a US$114 million Series C in December 2025.

Name

DP Technology

Legal name

北京深势科技股份有限公司

Website

https://dp.tech

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

101–250 employees

Short description

DP Technology is a Beijing-based AI for Science company founded in 2018 that builds Deep Potential molecular dynamics models and a Bohrium platform serving pharmaceutical, materials science, and academic researchers with integrated literature, computation, and laboratory tools across China and North America.

Ownership category

akta.pro rank

Product category

Scientific Computing Software

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Cheminformatics & Molecular Modeling / CADD (HLAGAJAE), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), LLMOps & Generative AI Platforms (Prompt/Agent Orchestration, RAG) (HDAEANAD)

Keywords

• AI for Science
• Drug discovery platform
• Molecular dynamics simulation
• Computational chemistry software
• Materials science R&D

Headquarters

HQ city

Haidian

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. SaaS / Platform Subscriptions: The company offers platform-based products including Bohrium (科学导航, 勒贝格智算), Hermite, RiDYMO, Piloteye, and Uni-Lab as subscription or license-based software products. The Bohrium Scholar platform covering 20M+ scholars suggests a platform/SaaS model with tiered access.
2. R&D Services: The company provides enterprise-level AI+ computing services and R&D services for life sciences (drug design, battery development) and materials science (new energy R&D, new materials R&D), likely structured as project-based or retainer engagements.
3. Enterprise Solutions: Customized enterprise-level AI solutions for organizations in life sciences and materials science sectors, combining software tools with computational infrastructure.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

DP Technology builds an AI for Science platform that combines molecular simulation, scientific AI models, and laboratory automation to serve life sciences, materials science, and chemistry R&D. Its offerings include the Bohrium scientific navigation workspace, the Hermite drug design platform, the RiDYMO hit discovery platform, Piloteye for materials science, and the Uni-Lab laboratory integration system.

Product overview

DP Technology operates as a unified platform-plus-modules architecture built on its proprietary 深势·宇知® (DP Scientific Discovery Intelligence Engine) as the foundational layer. The platform provides a Science as a Service intelligent research product and service matrix comprising 'reading documents, doing calculations, doing experiments' tools. The core Bohrium ecosystem includes 玻尔·科学导航 (Bohrium) for scientific navigation, 玻尔·勒贝格智算 for intelligent computing, and 玻尔·跃迁实验室 (Bohrium Transition Lab) for laboratory integration. Specialized applications include Hermite® for drug calculation, RiDYMO® for Hit discovery, and Piloteye® for materials science R&D. The SciMaster scientific AI agent system and supporting infrastructure (Uni-Lab, Jobs, Workspace, Nodes) complete the platform for fundamental research, life sciences, and materials science applications.

Differentiator

Problem solved

Functional benefit

Brands

• Bohrium (玻尔): Scientific research platform and navigation system providing academic resources and research tools including journal library, scholar coverage, and workspace
• Hermite
• RiDYMO
• Uni-Lab
• Piloteye
• SciMaster

Products and services

• Bohrium Scientific Navigation (玻尔·科学导航)

Quantifiable outcome

• Reduced time-to-insight in drug design and materials discovery through AI-accelerated molecular dynamics simulation
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Schrödinger: US-listed computational chemistry and molecular simulation company combining physics-based methods with AI/ML for drug and materials discovery — the closest Western analogue to DP Technology's Deep Potential simulation stack and Hermite/Piloteye product positioning.
• BenevolentAI: AI drug discovery company applying knowledge graphs and ML to identify novel drug targets and treatments — comparable enterprise AI-for-drug-discovery business model serving pharma R&D organizations.
• Recursion Pharmaceuticals: AI-driven drug discovery company combining high-throughput wet-lab experimentation with machine learning — comparable to DP Technology's integrated 'read-compute-experiment' workflow including Uni-Lab lab automation.
• XtalPi: Shenzhen-based AI drug discovery company using physics-informed AI and high-performance computing for crystal structure prediction and molecular design — directly comparable to DP Technology as a Chinese AI-for-drug-discovery peer with global pharma customers.
• Insilico Medicine: Hong Kong-headquartered AI-driven drug discovery company operating end-to-end from target identification to clinical-stage assets — overlaps with DP Technology's Hermite (computational drug design) and RiDYMO (Hit discovery) products.
• Citrine Informatics: AI platform for materials and chemicals R&D serving enterprise customers in batteries, alloys, and specialty chemicals — directly comparable to DP Technology's Piloteye materials science R&D software.
• Atomwise: AI small molecule discovery company using deep learning for hit identification and lead optimization — overlaps with DP Technology's RiDYMO Hit discovery platform and AI-for-drug-discovery positioning.
• Exscientia: AI-native pharma company using AI-driven drug design and active learning for small molecule discovery — directly comparable to DP Technology's life sciences stack (Hermite, RiDYMO).

Emerging players

• Iambic Therapeutics: AI-driven drug discovery company combining physics-based simulation with neural network potentials for small molecule design — closely comparable technical approach to DP Technology's Deep Potential architecture.
• METiS Therapeutics: China-based AI drug delivery and formulation company explicitly referenced in the company data as a peer — overlaps with DP Technology's AI-driven life sciences focus but with a narrower formulation/delivery niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/TheDPTechnology
• LinkedInlinkedin.com/company/dptechnology

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds8 records

Investors22 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DP Technology